BASF's Geismar Ribbon-Cutting Looms as Investors Weigh Raised Guidance Against a Bruised Sector

BASF has pencilled in 11 November 2026 for the formal opening of the third and final expansion stage of its MDI plant in Geismar, with the accompanying press releases slated to follow the same day. The ceremony gives shareholders a concrete date to circle — and a fresh test of whether the company's upgraded earnings story can hold up in a European chemicals industry that Lanxess chief Matthias Zachert described only yesterday as mired in a particularly severe downturn.

That question has taken on more urgency after the stock came under pressure in a broad retreat. Reuters reported that the selloff in technology shares across the US and Asia spilled into European equities, with BASF among the losers on Germany's benchmark DAX. The shares were down 3.2% on the day, according to one reading of the move, while a separate snapshot put the decline at 2.5% — either way, a session that pushed the operating debate back to centre stage.

Guidance Raised, but the Fourth Quarter Is the Real Test

Roughly a week ago the chemicals group lifted its full-year 2026 guidance for EBITDA before special items to a range of EUR 7.4bn to EUR 7.8bn, up from the previous EUR 6.9bn to EUR 7.7bn. The upgrade signals management's confidence in higher operating earnings power despite the tough backdrop.

The third quarter offered supporting evidence. Sales climbed 14% year on year to EUR 16.4bn, while EBITDA before special items rose 15% to EUR 1.6bn. Yet analysts responding to the quarterly report — as reported by dpa-AFX — flagged an outlook for the closing quarter that sat below market expectations. The burden of proof therefore rests on the final three months: BASF must show that the improved momentum can survive weak demand and cost pressure, and that it can clear the more cautious bar the market has set for year-end.

Should investors sell immediately? Or is it worth buying BASF?

Awards, Capacity and a Steady Buyback

Product-level wins have added colour to the positive case. BASF, together with Toyota and Vuteq, collected the SPE Automotive Innovation Grand Award as well as the prize in the "Body Exterior" category for the thermoplastic bed of the Toyota Tacoma. Further honours went to joint projects with Stellantis and L&L Products, and with Ford and Supavut Thailand, covering a composite tunnel reinforcement and interior door-handle trim respectively. The commercial question is whether such applications translate into future volumes and earnings.

On the capacity side, BASF brought expanded alkylpolyglucoside production on stream at its Cincinnati site on 27 October. Alongside that, the company confirmed on Monday that it had bought back a further 355,128 of its own shares over the period from 26 to 30 October inclusive. Since the programme began on 3 August, a total of 7,595,230 shares had been repurchased through 30 October. The combination of organic investment and capital returns paints a picture of a group funding both growth and shareholder payouts.

A Sector Headwind That Won't Let Up

The counterargument is hard to dismiss. Reuters cited weak demand, high energy costs and mounting regulation as the pressures bearing down on European chemicals — forces that could complicate BASF's earnings trajectory if they persist or intensify. The most uncomfortable scenario for investors is one in which sector weakness collides with disappointing fourth-quarter expectations, forcing BASF to defend its raised targets under harsher conditions. Extra capacity, in that case, would raise the bar on utilisation and demand.

Analyst reactions on 29 October captured the split. UBS reiterated a neutral rating with a price target of EUR 55. JPMorgan lifted its target to EUR 42 while keeping an "Underweight" stance.

What to Watch Next

For now, the improved quarterly figures argue in BASF's favour so long as it can back the higher guidance with delivery. Should demand deteriorate and the closing quarter come under heavier strain, the more cautious reading gains traction — with earnings power in difficult markets remaining the yardstick. Beyond the Geismar opening on 11 November, the next confirmed capital-markets date is BASF's Capital Markets Day on 23 November, where commentary on demand and the economic use of the new capacity could tip the balance one way or the other.

Ad

BASF Stock: New Analysis - 6 November

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...